EUVIMEDEUVIMED entdecken
Validierungsstudie

A Validated Multi‐Analyte Liquid Chromatography–Tandem Mass Spectrometry Method for Simultaneous Therapeutic Drug Monitoring and Targeted Toxicological Assessment of 54 Drugs and Metabolites in Human Serum

Katerina Kratka, Pavel Sistik, Radek Jerga, Ivana Olivkova, Hana Brozmanova, Romana Urinovska, Vladimira Gebauerova, Jan Jurica, Klara Handlosova, Petr Handlos, Ivana Kacirova, David Stejskal

Journal of Separation Science · 2026-10 · 49 (10)

DOI: 10.1002/jssc.70560 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Journal of Separation Science, online erschienen am 21.10.2026. Verfasst von Katerina Kratka und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Laboratory Medicine, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. Hauptthemen laut MEDLINE: Drug Monitoring, Anticonvulsants, Antidepressive Agents. Die Arbeit nennt 48 Literaturangaben. Gefördert von: European Union, the Operational Program Just Transition, European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapeutic drug monitoring and targeted toxicological assessment require quantitative methods capable of covering chemically diverse drugs over clinically relevant concentration ranges. We developed and validated a liquid chromatography–tandem mass spectrometry method for the simultaneous determination of 54 analytes in human serum, including antiepileptic drugs, antidepressants, antipsychotics, benzodiazepines, antifungal agents, theophylline, and selected clinically relevant metabolites. Serum samples were prepared by protein precipitation with perchloric acid. Chromatographic separation was achieved on an ACQUITY UPLC BEH C18 column using water/methanol mobile phases containing 2 mM ammonium acetate. Detection was performed in polarity‐switching selected reaction monitoring mode using two transitions per analyte and 28 isotope‐labeled or structurally related internal standards. The total run time was 8.5 min. Analyte‐specific calibration models and validated concentration ranges covered 0.1–22,500 ng/mL, depending on the analyte. The method demonstrated acceptable selectivity, calibration performance, accuracy, precision, matrix effects, and stability under routine handling and storage conditions for analytes with available data. Within‐run and between‐run precision did not exceed 14.3% and 13.9%, respectively. Matrix effects ranged from −8.35% to +10.25%. Application to 120 remnant patient serum samples supported the feasibility of multiplex measurement of drugs from several therapeutic classes in a single analytical run. The method is suitable for routine serum‐based therapeutic drug monitoring and for targeted toxicological interpretation of a predefined analyte panel.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug MonitoringAnticonvulsantsAntidepressive AgentsHumansTandem Mass SpectrometryLiquid Chromatography-Mass SpectrometryBenzodiazepinesTheophyllineAntifungal AgentsAntipsychotic AgentsChromatography, Liquid

Stichwörter der Autor:innen

antiepilepticshuman serummultiparametric analysispsychotropicstoxicology

Substanzen

AnticonvulsantsBenzodiazepinesAntidepressive AgentsTheophyllineAntifungal AgentsAntipsychotic Agents

Autor:innen und Institutionen

  • Institute of Laboratory Medicine, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Institute of Laboratory Medicine, University Hospital Ostrava, Ostrava, Czech Republic.
  • Lab4Life Ostrava FNOU, Ostrava, Czech Republic.
  • Institute of Forensic Medicine, University Hospital Ostrava, Ostrava, Czech Republic.
  • Science, Research and Education, University Hospital Ostrava, Ostrava, Czech Republic.
  • Department of Clinical Pharmacology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.

Förderung

  • European Union
  • the Operational Program Just Transition
  • European Commission

Zitieren

APA

Kratka, K., Sistik, P., Jerga, R., Olivkova, I., Brozmanova, H., Urinovska, R., Gebauerova, V., Jurica, J., Handlosova, K., Handlos, P., Kacirova, I., & Stejskal, D. (2026). A Validated Multi‐Analyte Liquid Chromatography–Tandem Mass Spectrometry Method for Simultaneous Therapeutic Drug Monitoring and Targeted Toxicological Assessment of 54 Drugs and Metabolites in Human Serum. Journal of Separation Science, 49(10). https://doi.org/10.1002/jssc.70560

Vancouver

Kratka K, Sistik P, Jerga R, Olivkova I, Brozmanova H, Urinovska R, et al. A Validated Multi‐Analyte Liquid Chromatography–Tandem Mass Spectrometry Method for Simultaneous Therapeutic Drug Monitoring and Targeted Toxicological Assessment of 54 Drugs and Metabolites in Human Serum. Journal of Separation Science. 2026;49(10). doi:10.1002/jssc.70560

BibTeX
@article{Kratka2026,
  author = {Kratka, Katerina and Sistik, Pavel and Jerga, Radek and Olivkova, Ivana and Brozmanova, Hana and Urinovska, Romana and Gebauerova, Vladimira and Jurica, Jan and Handlosova, Klara and Handlos, Petr and Kacirova, Ivana and Stejskal, David},
  title = {A Validated Multi‐Analyte Liquid Chromatography–Tandem Mass Spectrometry Method for Simultaneous Therapeutic Drug Monitoring and Targeted Toxicological Assessment of 54 Drugs and Metabolites in Human Serum},
  journal = {Journal of Separation Science},
  year = {2026},
  volume = {49},
  number = {10},
  doi = {10.1002/jssc.70560}
}
Kostenlos starten →